• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

by Fred Pennic 09/15/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

What You Should Know:

– XRHealth has just received a patent for its approach to incorporate biofeedback from devices such as an Apple watch into its remote healthcare therapy platform that utilizes virtual/artificial reality (VR/AR).

– XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical-grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat.


XRHealth, the leader in extended reality therapeutic applications, announces that they received a patent to utilize approaches that incorporate biofeedback into their extended reality therapy.  U.S. Patent No. 16/067,480, entitled “A Therapy and Physical Training Device,” was issued on September 15, 2020. 

These novel approaches enable VR/AR therapy to address patient pain based on biofeedback such us heart rate variability, EEG, galvanic skin response, and other critical responses while patients are using the VR/AR devices.  Solutions that incorporate biofeedback allow patient treatment to be customized according to their unique needs and better inform clinicians on how patients are responding to therapy.

VR/AR therapy Integration with Apple Watch

XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat. XRHealth will use the output measurements of the Apple Watch to detect pain, which will modify VR/AR therapy treatment for patients based on the pain that they feel during the sessions.

“The newly awarded patent reflects XRHealth’s commitment to creating the most sophisticated form of therapy that responds to patient physical needs in real-time,” said Eran Orr, CEO of XRHealth. “Virtual Reality therapy that incorporates biofeedback will enhance and personalize the patient experience and provide clinicians with critical insights.” 

XRHealth created the first virtual reality telehealth clinic in the world that treats multiple conditions like anxiety & stress, cognitive impairment, pain management, Parkinson’s, and multiple sclerosis. XRHealth provides doctors with patient data that allows them to monitor and treat them in real-time.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: apple, Apple Watch, Augmented Reality, FDA, Heart, Pain Management, Patient Experience, Virtual Reality, XRHealth

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |